Conceptio
›
ovarian-cancer
Topic
ovarian-cancer
Knowledge-graph topic
· documents ABOUT ovarian-cancer across the archive
586
Documents about ovarian-cancer
Documents about ovarian-cancer
CA-125 in Screening Patients at High Risk for Ovarian Cancer
#848802
ClinicalTrials.gov
Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer
#878360
ClinicalTrials.gov
Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
#143583
ClinicalTrials.gov
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival
#833479
ClinicalTrials.gov
Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients
#853592
ClinicalTrials.gov
Registry Platform Ovarian and Endometrial Cancer
#911605
ClinicalTrials.gov
A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer
#811581
ClinicalTrials.gov
AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer
#651247
ClinicalTrials.gov
Long Term Survivors in Ovarian Cancer
#810060
ClinicalTrials.gov
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
#833343
ClinicalTrials.gov
An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer
#859715
ClinicalTrials.gov
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
#825963
ClinicalTrials.gov
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
#885740
ClinicalTrials.gov
Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
#918413
ClinicalTrials.gov
Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer
#314349
ClinicalTrials.gov
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
#843117
ClinicalTrials.gov
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
#843995
ClinicalTrials.gov
Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer
#902938
ClinicalTrials.gov
Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma
#846627
ClinicalTrials.gov
Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility
#850650
ClinicalTrials.gov
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
#172300
ClinicalTrials.gov
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
#892251
ClinicalTrials.gov
Neoadjuvant Therapy for Ovarian Cancer
#898436
ClinicalTrials.gov
Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
#140933
ClinicalTrials.gov
Prediction of Ovarian Cancer Histotypes and Surgical Outcome
#912268
ClinicalTrials.gov
Blood Collection From People With Ovarian Cancer
#862418
ClinicalTrials.gov
Autologous OC-DC Vaccine in Ovarian Cancer
#387210
ClinicalTrials.gov
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
#855819
ClinicalTrials.gov
Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
#146312
ClinicalTrials.gov
Lymphadenectomy in Early Ovarian Cancer
#847864
ClinicalTrials.gov
Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143)
#904445
ClinicalTrials.gov
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer
#881423
ClinicalTrials.gov
Ovarian Screening Study
#900570
ClinicalTrials.gov
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
#895771
ClinicalTrials.gov
C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
#871511
ClinicalTrials.gov
Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer
#356532
ClinicalTrials.gov
Pilot Study Evaluating the Oncogramme: Analysis of Response to Induction Treatment of Patients With Breast or Ovarian Cancer.
#851025
ClinicalTrials.gov
Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
#829667
ClinicalTrials.gov
DOXIL for Consolidation Therapy in Ovarian Cancer.
#890063
ClinicalTrials.gov
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
#918415
ClinicalTrials.gov
Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
#831976
ClinicalTrials.gov
SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours
#834196
ClinicalTrials.gov
Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
#801670
ClinicalTrials.gov
Autologous OC-L Vaccine and Ovarian Cancer
#405220
ClinicalTrials.gov
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
#856462
ClinicalTrials.gov
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
#893075
ClinicalTrials.gov
Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer
#885596
ClinicalTrials.gov
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
#914223
ClinicalTrials.gov
Cost Utility of Radical Surgery in Ovarian Cancer
#804830
ClinicalTrials.gov
Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.
#857389
ClinicalTrials.gov
← Previous
Page 2 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.